Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 397

1.

Office-Based Mesenchymal Stem Cell Therapy for the Treatment of Musculoskeletal Disease: A Systematic Review of Recent Human Studies.

Law L, Hunt CL, van Wijnen AJ, Nassr A, Larson AN, Eldrige JS, Mauck WD, Pingree MJ, Yang J, Muir CW, Erwin PJ, Bydon M, Qu W.

Pain Med. 2018 Dec 29. doi: 10.1093/pm/pny256. [Epub ahead of print]

PMID:
30597057
2.

The characteristics of cervical sagittal alignment at different C0-C2 correcting angles in fusion treatment of atlantoaxial dislocations.

Xiuru Z, Kun G, Huiqi X, Yanzheng G.

World Neurosurg. 2018 Dec 21. pii: S1878-8750(18)32839-0. doi: 10.1016/j.wneu.2018.12.017. [Epub ahead of print]

PMID:
30583133
3.

Photopolymerizable Biogel Scaffold Seeded with Mesenchymal Stem Cells: Safety and Efficacy Evaluation of Novel Treatment for Intervertebral Disc Degeneration.

Vaudreuil N, Henrikson K, Pohl P, Lee A, Lin H, Olsen A, Dong Q, Dombrowski M, Kang J, Vo N, Lee J, Sowa G.

J Orthop Res. 2018 Dec 18. doi: 10.1002/jor.24208. [Epub ahead of print]

PMID:
30561043
4.

Evaluation of regenerative processes in the pig model of intervertebral disc degeneration after transplantation of bone marrow-derived mesenchymal stem cells.

Barczewska M, Jezierska-Wozniak K, Habich A, Lipinski S, Holak P, Maksymowicz W, Wojtkiewicz J.

Folia Neuropathol. 2018;56(2):124-132. doi: 10.5114/fn.2018.76616.

5.

Mesenchymal Stem Cells Induced by Microencapsulated Chondrocytes on Repairing of Intervertebral Disc Degeneration.

Zhang ZQ, Wang CS, Yang P, Wang KZ.

Orthop Surg. 2018 Nov;10(4):328-336. doi: 10.1111/os.12411.

PMID:
30485683
6.
7.

Autogenic mesenchymal stem cells for intervertebral disc regeneration.

Migliorini F, Rath B, Tingart M, Baroncini A, Quack V, Eschweiler J.

Int Orthop. 2018 Nov 10. doi: 10.1007/s00264-018-4218-y. [Epub ahead of print] Review.

PMID:
30415465
8.

Effect of Compression Loading on Human Nucleus Pulposus-Derived Mesenchymal Stem Cells.

Liang H, Chen S, Huang D, Deng X, Ma K, Shao Z.

Stem Cells Int. 2018 Oct 8;2018:1481243. doi: 10.1155/2018/1481243. eCollection 2018.

9.
10.

Injectable decellularized nucleus pulposus-based cell delivery system for differentiation of adipose-derived stem cells and nucleus pulposus regeneration.

Zhou X, Wang J, Huang X, Fang W, Tao Y, Zhao T, Liang C, Hua J, Chen Q, Li F.

Acta Biomater. 2018 Nov;81:115-128. doi: 10.1016/j.actbio.2018.09.044. Epub 2018 Sep 27.

PMID:
30267879
11.

Mechanisms of endogenous repair failure during intervertebral disc degeneration.

Ma K, Chen S, Li Z, Deng X, Huang D, Xiong L, Shao Z.

Osteoarthritis Cartilage. 2019 Jan;27(1):41-48. doi: 10.1016/j.joca.2018.08.021. Epub 2018 Sep 19. Review.

PMID:
30243946
12.

Differentiation of pluripotent stem cells into nucleus pulposus progenitor cells for intervertebral disc regeneration.

Xia K, Gong Z, Zhu J, Yu W, Wang Y, Wang J, Xu A, Zhou X, Tao H, Li F, Liang C.

Curr Stem Cell Res Ther. 2018 Sep 17. doi: 10.2174/1574888X13666180918095121. [Epub ahead of print]

PMID:
30227822
13.

Umbilical cord mesenchymal stem cell conditioned medium restored the expression of collagen II and aggrecan in nucleus pulposus mesenchymal stem cells exposed to high glucose.

Qi L, Wang R, Shi Q, Yuan M, Jin M, Li D.

J Bone Miner Metab. 2018 Sep 5. doi: 10.1007/s00774-018-0953-9. [Epub ahead of print]

PMID:
30187277
14.

Upregulation of glycosaminoglycan synthesis by Neurotropin in nucleus pulposus cells via stimulation of chondroitin sulfate N-acetylgalactosaminyltransferase 1: A new approach to attenuation of intervertebral disc degeneration.

Sakai D, Nakai T, Hiraishi S, Nakamura Y, Ando K, Naiki M, Watanabe M.

PLoS One. 2018 Aug 27;13(8):e0202640. doi: 10.1371/journal.pone.0202640. eCollection 2018.

15.

Therapeutic effects of cell therapy with neonatal human dermal fibroblasts and rabbit dermal fibroblasts on disc degeneration and inflammation.

Shi P, Chee A, Liu W, Chou PH, Zhu J, An HS.

Spine J. 2019 Jan;19(1):171-181. doi: 10.1016/j.spinee.2018.08.005. Epub 2018 Aug 22.

PMID:
30142460
16.
17.

Fibroblasts as a practical alternative to mesenchymal stem cells.

Ichim TE, O'Heeron P, Kesari S.

J Transl Med. 2018 Jul 27;16(1):212. doi: 10.1186/s12967-018-1536-1. Review.

18.

Co-culturing nucleus pulposus mesenchymal stem cells with notochordal cell-rich nucleus pulposus explants attenuates tumor necrosis factor-╬▒-induced senescence.

Li XC, Wang MS, Liu W, Zhong CF, Deng GB, Luo SJ, Huang CM.

Stem Cell Res Ther. 2018 Jun 26;9(1):171. doi: 10.1186/s13287-018-0919-9.

19.

FoxA2 regulates the type II collagen-induced nucleus pulposus-like differentiation of adipose-derived stem cells by activation of the Shh signaling pathway.

Zhou X, Ma C, Hu B, Tao Y, Wang J, Huang X, Zhao T, Han B, Li H, Liang C, Chen Q, Li F.

FASEB J. 2018 Jun 11:fj201800373R. doi: 10.1096/fj.201800373R. [Epub ahead of print]

PMID:
29890089
20.

Bone mesenchymal stem cells attenuate radicular pain by inhibiting microglial activation in a rat noncompressive disk herniation model.

Huang X, Wang W, Liu X, Xi Y, Yu J, Yang X, Ye X.

Cell Tissue Res. 2018 Oct;374(1):99-110. doi: 10.1007/s00441-018-2855-5. Epub 2018 Jun 1.

PMID:
29858667

Supplemental Content

Loading ...
Support Center